0       0

31st Annual North American Cystic Fibrosis Conference


W12 - W12: CFTR: Toward a One Time Cure: Technologies & Editing


Nov 3, 2017 2:00pm ‐ Nov 3, 2017 3:20pm

Description

This session will highlight new technologies and gene editing strategies that will move the field towards a one time cure.

Learning Objectives:

  1. Describe the potential power of CRISPR CAS9 based gene editing platforms for drug development and a one time cure
  2. Discuss the advantages of engineered tRNA for suppression of CFTR nonsense mutations
  3. Test the efficiency of oligonucleotide mediated therapy to restore CFTR function

Note: Speaker Adele Ricciardi's presentation was not recorded at their request.

Workshop Chair(s):

Workshop Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content